Evidence map›Paper›PMID 31635288›Full record

ArticleJournal of clinical medicine2019

Monitoring and Determining Mitochondrial Network Parameters in Live Lung Cancer Cells.

Tamara Mirzapoiazova, Haiqing Li, Anusha Nathan, Saumya Srivstava, Mohd W Nasser, Frances Lennon, Brian Armstrong, Isa Mambetsariev, Peiguo G Chu, Srisairam Achuthan and 3 more

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tamara MirzapoiazovaDepartment of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA. tmirzapoiazova@coh.org.
Haiqing LiCenter for Informatics, City of Hope National Medical Center, Duarte, CA 91010, USA. hali@coh.org.
Anusha NathanDepartment of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA. anathan@coh.org.
Saumya SrivstavaDepartment of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA. ssrivastava@coh.org.
Mohd W NasserUniversity of Nebraska, Medical Center, Nebraska, NE 68198, USA. wasim.nasser@unmc.edu.
Frances LennonAbbott Molecular, Des Plaines, IL 60018, USA. franlen@gmail.com.
Brian ArmstrongDepartment of Developmental and Stem Cell Biology, City of Hope National Medical Center, Duarte, CA 91010, USA. BArmstrong@coh.org.
Isa MambetsarievDepartment of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA. Imambetsariev@coh.org.
Peiguo G ChuDepartment of Anatomic Pathology, City of Hope National Medical Center, Duarte, CA 91010, USA. PChu@coh.org.
Srisairam AchuthanCenter for Informatics, City of Hope National Medical Center, Duarte, CA 91010, USA. sachuthan@coh.org.
Surinder K BatraUniversity of Nebraska, Medical Center, Nebraska, NE 68198, USA. sbatra@unmc.edu.ORCID 0000-0001-9470-9317
Prakash KulkarniDepartment of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA. pkulkarni@coh.org.
Ravi SalgiaDepartment of Medical Oncology and Therapeutics Research, City of Hope National Medical Center, Duarte, CA 91010, USA. rsalgia@coh.org.ORCID 0000-0001-9643-7626

Funding

Transgenic Mouse FacilityP30CA033572 · NCI · CITY OF HOPE/BECKMAN RESEARCH INSTITUTE · PI XIWEI WU · 1985 to 2026
$86.3M
Project 2: Targeting Cooperative Phenotypes Common in Spatial HeterogeneityU54CA209978 · NCI · UNIVERSITY OF UTAH · PI MOOS, PHILIP J · 2017 to 2021
$10.5M
Novel approach to attenuate small cell lung cancer growth and metastasisR01CA218545 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI NASSER, MOHD WASIM · 2018 to 2022
$2.6M
NCI NIH HHS P30 CA033572NCI NIH HHS R01 CA218545NCI NIH HHS U54 CA209978
6 · The paper itself

Abstract

Mitochondria are dynamic organelles that constantly fuse and divide, forming dynamic tubular networks. Abnormalities in mitochondrial dynamics and morphology are linked to diverse pathological states, including cancer. Thus, alterations in mitochondrial parameters could indicate early events of disease manifestation or progression. However, finding reliable and quantitative tools for monitoring mitochondria and determining the network parameters, particularly in live cells, has proven challenging. Here, we present a 2D confocal imaging-based approach that combines automatic mitochondrial morphology and dynamics analysis with fractal analysis in live small cell lung cancer (SCLC) cells. We chose SCLC cells as a test case since they typically have very little cytoplasm, but an abundance of smaller mitochondria compared to many of the commonly used cell types. The 2D confocal images provide a robust approach to quantitatively measure mitochondrial dynamics and morphology in live cells. Furthermore, we performed 3D reconstruction of electron microscopic images and show that the 3D reconstruction of the electron microscopic images complements this approach to yield better resolution. The data also suggest that the parameters of mitochondrial dynamics and fractal dimensions are sensitive indicators of cellular response to subtle perturbations, and hence, may serve as potential markers of drug response in lung cancer.

Indexed as

dynamicsfractalsimaginglung cancermitochondriamorphologyscanning electron microscopy

Identifiers

PMID31635288
PMCPMC6832496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.